These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12969994)

  • 1. " 'Tis a gift to be simple...".
    Wunderink RG
    Chest; 2003 Sep; 124(3):777-8. PubMed ID: 12969994
    [No Abstract]   [Full Text] [Related]  

  • 2. Early mobilization of patients hospitalized with community-acquired pneumonia.
    Mundy LM; Leet TL; Darst K; Schnitzler MA; Dunagan WC
    Chest; 2003 Sep; 124(3):883-9. PubMed ID: 12970012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's in a day?
    Milbrandt EB; Angus DC
    Chest; 2005 Nov; 128(5):3091-3. PubMed ID: 16304247
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical and economic aspects of treating community-acquired pneumonias].
    Tiurin VP; Dmitriev IuK; Duganov VK; Bogdanov MB
    Voen Med Zh; 2000 Apr; 321(4):28-31. PubMed ID: 10860468
    [No Abstract]   [Full Text] [Related]  

  • 5. Hospitalised low-risk community-acquired pneumonia: outcome and potential for cost-savings.
    Lee KH; Chin NK; Tan WC; Lim TK
    Ann Acad Med Singap; 1999 May; 28(3):389-91. PubMed ID: 10575524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How long a stay in the hospital is needed for patients with community-acquired pneumonia?
    Siegel RE
    Am J Med; 2000 Oct; 109(5):434-6. PubMed ID: 11020402
    [No Abstract]   [Full Text] [Related]  

  • 7. A population-based study of the costs of care for community-acquired pneumonia.
    Bartolomé M; Almirall J; Morera J; Pera G; Ortún V; Bassa J; Bolíbar I; Balanzó X; Verdaguer A;
    Eur Respir J; 2004 Apr; 23(4):610-6. PubMed ID: 15083763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic burden of community-acquired pneumonia among adults in Europe.
    Welte T; Torres A; Nathwani D
    Thorax; 2012 Jan; 67(1):71-9. PubMed ID: 20729232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INNOVATION. SMALL STEPS, GIANT LEAPS.
    Trueland J
    Health Serv J; 2015 Oct; 125(6465):22-3. PubMed ID: 26875415
    [No Abstract]   [Full Text] [Related]  

  • 10. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
    Samsa GP; Matchar DB; Harnett J; Wilson J
    Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gemifloxacin in community-acquired pneumonia.
    Tillotson GS
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacoeconomic estimation of cost of community acquired pneumonia therapy].
    Kulidzhanov AIu; Sirotko II; Koriakin PM; Korchazhkin VS
    Voen Med Zh; 2001 Jan; 322(1):50-2. PubMed ID: 11219929
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing postacute hospital care: a case for biopsychosocial needs.
    Luthy C; Cedraschi C; Rutschmann OT; Kossovsky MP; Allaz AF
    J Psychosom Res; 2007 May; 62(5):513-9. PubMed ID: 17467405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-acquired pneumonia: need for a cost-effective approach to treatment.
    Prabhudesai PP; Kuruvilla T; Tadvi S
    Chest; 1997 Sep; 112(3):861-2. PubMed ID: 9315836
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of the implementation of an intervention protocol in community-acquired pneumonia].
    Ramírez-Montesinos R; Moreno-Arias CV; Carulla-Aresté M; Pedrol-Clotet E
    Med Clin (Barc); 2012 Nov; 139(12):558-9. PubMed ID: 22698710
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region.
    Song JH; Thamlikitkul V; Hsueh PR
    Int J Antimicrob Agents; 2011 Aug; 38(2):108-17. PubMed ID: 21683553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia.
    Friedman H; Song X; Crespi S; Navaratnam P
    Value Health; 2009; 12(8):1135-43. PubMed ID: 19695010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of early ambulation with length of stay and costs in total knee arthroplasty: retrospective cohort study.
    Pua YH; Ong PH
    Am J Phys Med Rehabil; 2014 Nov; 93(11):962-70. PubMed ID: 24879549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
    Orrick JJ; Segal R; Johns TE; Russell W; Wang F; Yin DD
    Pharmacoeconomics; 2004; 22(11):751-7. PubMed ID: 15250752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.